Search Science Hub

Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.

Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

EASD 2026 28 September - 2 October 2026

Blood pressure changes with once-weekly semaglutide 7.2 mg in adults with obesity: post hoc analysis of the STEP UP randomised, controlled trial

Authors :

Jøran Hjelmesæth¹,²; Paula Freitas³,⁴; Christine Sofie Fuchs Jacobsen⁵; Hanna Angelene Kudiyanur Muniraju⁶; Signe Stensen⁵; W. Timothy Garvey⁷

Affiliations

View Details Hide Details

Download poster (.pdf)

Keywords

Obesity

Congress oral presentation

GLP-1 RA

Semaglutide

PHASE 3 (RCT)